Though typically discarded, some zygotes diagnosed as 3+PNs have been found to be diploid and euploid, and even capable of resulting in live births.1 Our objective was to assess the ploidy of
Endometriosis, a debilitating disease affecting 10-15% of all women, was described over 100 years ago, yet the only reliable diagnostic is abdominal surgery. Imaging only detects advanced disease
Asthenozoospermia (ASZ) accounts for about 20%-40% of male infertility, and genetic factors, contributing to 30%-40% of the causes of ASZ, still need further exploration. Radial spokes (RSs), a
To evaluate the landscape of oncology clinical trials in the United States (US), given the expansion of novel therapeutic agents and lack of information on potential gonadotoxicity. New FDA draft
To investigate whether elevated sperm double-strand breaks (DSBs) are associated with the prevalence of high-level mosaic embryos in ICSI cycles with preimplantation genetic testing for aneuploidy
To evaluate the fertility preservation outcomes after COH in women with breast cancer at different clinical stages before receiving radiotherapy and chemotherapy.
To evaluate the reliability of aneuploidy results from Preimplantation Genetic Testing for Aneuploidy (PGT-A) by comparing them with results from non-invasive PGT (ni-PGT) using spent culture media
To assess current expanded carrier screening (ECS) practices and policies among reproductive endocrinology and infertility (REI) physicians.
To compare the euploidy rates of blastocysts in PGT for aneuploidy following Conventional and Minimal Stimulation Protocols.
Displaying 1311 to 1320 of 2641 records
